Towards Healthcare

3D Cell Culture Companies and Market Trends Analysis

Date : 11 November 2025

Who’s Leading the Way in the 3D Cell Culture Market

3D Cell Culture Market Companies

  • Thermo Fisher Scientific, Inc.
  • Lena Biosciences
  • PromoCell GmbH
  • Merck KGaA
  • Corning Incorporated
  • REPROCELL Inc.
  • Tecan Trading AG
  • Avantor, Inc.
  • Lonza
  • HiMedia
  • CN Bio Innovations Ltd

Market Growth

The global 3D cell culture market was estimated at US$ 2.10 billion in 2023 and is projected to grow to US$ 7.02 billion by 2034, rising at a compound annual growth rate (CAGR) of 11.6% from 2024 to 2034.

3D Cell Culture Market Revenue 2023 - 2034

  • Growing Research and Development Activities: The growing demand for new drug discovery and development and stem cell research drives the market.
  • Rising Incidences of Chronic Disorders: Chronic disorders such as cancer, autoimmune, and neurological disorders promote R&D for their effective treatments, thereby promoting market growth.
  • Increasing Investments: Several government and private organizations provide funding to research institutions and organizations for conducting advanced research.
  • Technological Advancements: Advanced technologies such as artificial intelligence and machine learning augment the research process involving 3D cell culture technique.

Company Insights

  • In April 2024, Predictive Oncology Inc., a business that specializes in biologics and artificial intelligence-driven drug development, announced the introduction of its sophisticated 3D cell culture model. The model is intended to improve the process of finding cancer treatments. With their near resemblance to human tissue, the novel organ-specific in vitro models can potentially enhance clinical outcome prediction and expedite the drug development process.
  • In August 2024, the University of Georgia firm CytoNest Inc. unveiled its first commercial product, a fiber scaffold that enhances tissue engineering and cell production. The product, known as CytoSurge 3D fiber scaffold, is useful for cell research, biopharmaceuticals, cell therapies, and the generation of cultured meat and seafood.

Recent Launches in the 3D Cell Culture Market

1. HiMedia

  • Headquarters: Maharashtra, India, Asia Pacific

  • Date: June 2024

  • Overview: HiMedia Laboratories, a renowned biotechnology company based in Mumbai, announced the launch of its state-of-the-art Center of Excellence (CoE) for 3D Cell Culture Laboratory.

  • Key Highlights:

    • The CoE is designed to advance collaborative research and scientific innovation in the areas of 3D cell culture and bioprinting.

    • Represents a major milestone in India’s biotechnology landscape, promoting advanced cell-based research infrastructure.

  • Impact: Strengthens HiMedia’s position as a leader in biotechnology and demonstrates its commitment to enhancing scientific collaboration and innovation in 3D cell culture technologies.

2. Cell Microsystems

  • Headquarters: North Carolina, U.S., North America

  • Date: February 2024

  • Overview: Cell Microsystems, a leading provider of advanced cell biology instruments, announced a strategic collaboration with OMNI Life Science (OLS), a prominent German cell biology company.

  • Key Highlights:

    • The partnership introduces three groundbreaking products — CERO, CASY, and TIGR — to the U.S. and Canadian markets.

    • The CERO 3D device is a revolutionary innovation that creates an optimal cell culture environment for generating 3D cell culture models.

    • Enables the production of stem cells, spheroids, organoids, and even tissue structures.

  • Impact: This collaboration significantly advances life science research in North America, expanding access to cutting-edge 3D cell culture technologies and promoting innovation in regenerative medicine and cell biology.

 

Latest Announcements by Industry Leaders

Eric Perreault, CEO of Kiyatec, Inc., was appointed as the new CEO of Kiyatec, Inc., a leading biotechnology company specializing in 3D cell culture technology. He envisions driving the company toward truly revolutionizing cancer care, especially for brain cancer patients, using 3D cell culture technology, ultimately improving patient outcomes.

Recent Developments in the 3D Cell Culture Market

  • In August 2024, Cell Microsystems, a pioneer in cutting-edge instruments for cell biology, announced the growth of its internal contract research lab services. Using their cutting-edge CellRaft® Technology, these services include the generation of cell lines, bespoke organoids, and tests.
  • In June 2024, Predictive Oncology, a biologics and drug discovery business, introduced its 3D cell culture model to help find new cancer treatments and expedite future drug development. In vitro organ and disease-specific models have been created by Predictive Oncology to precisely mimic the physiological milieu of human tissue.
  • In June 2023, Nova Scotia's Halifax 3DBLeading tissue engineering inventor ioFibR announced the release of two new collagen fiber products: CollaFibRTM 3D scaffold and μCollaFibRTM (called micro-CollaFibRTM). Produced utilizing 3D BioFibR's unique and innovative dry-spinning technique to generate collagen fibers on a commercial scale, these readily available materials have noteworthy benefits for tissue engineering and tissue culture uses.

Collaborate with our experts to explore the 3D Cell Culture Market at sales@towardshealthcare.com